Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells.

In the supF gene, most (+)-anti-benzo[a]pyrene diol epoxide ((+)-anti-B[a]PDE) mutagenesis hot spots in Escherichia coli are in 5'-GG sequences [Rodriguez and Loechler (1993) Carcinogenesis 14, 373-383]. A major hot spot was detected at G1 in the sequence 5'-GCG1G2-CCAAAG, whereas G2 yielded very few mutants. In order to investigate the details of such sequence context effects of (+)-anti-B[a]PDE mutagenesis, we have constructed 25-mer oligonucleotides and single-stranded M13 genomes containing the above decamer sequence, in which the trans-N2-dG adduct induced by (+)-anti-B[a]PDE [(+)-trans-anti-B[a]P-N2-dG] at G1 or G2 was introduced. In vitro DNA synthesis on the adducted 25-mers was strongly blocked at each site, although the 3'-->5' exonuclease-deficient Klenow fragment could incorporate a nucleotide opposite the adduct in the presence of Mn2+. For both sites purine nucleotides were preferred. The ratio Vmax/K(m) indicated that the efficiency of incorporation of dGTP opposite these sites was very similar, but dATP incorporation opposite the adduct at G1 was five-fold more efficient than that at G2. For each site, further extension beyond the adducted nucleotide was investigated by annealing four different primers, in which only the nucleotide opposite the adducted deoxyguanosine was altered. Significant extension was only observed when deoxyadenosine was located opposite adducted G1. When the M13 genomes containing the (+)-trans-anti-B[a]P-N2-dG were replicated in E. coli, survival of each adducted genome was less than 1% as compared to the unadducted genome. Upon induction of SOS, viability increased 2-6-fold. DNA sequencing showed no base substitutions in the progeny from SOS-uninduced cells, although small deletions in a quasipalindromic sequence occurred with the adduct being located at either site. However, following SOS induction, up to 40% targeted base substitutions were detected when the adduct was located at G1, while approximately 12% of the progeny were mutants with the adduct at G2. Most base substitutions were targeted G-->T transversions. We conclude that (+)-trans-anti-B[a]P-N2-dG is a highly mutagenic and replication blocking lesion. In addition, the biological consequence of this adduct depends on whether it is located at G1 or G2, suggesting that sequence context plays a major role in the mutagenic processing of this adduct.

[1]  S. Spiegel,et al.  Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2'-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality. , 1996, Biochemistry.

[2]  E. Loechler The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems. , 1996, Carcinogenesis.

[3]  A. Basu,et al.  Site-specific frame-shift mutagenesis by the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-y1)-1-aminopyrene located in the (CG)3 sequence: effects of SOS, proofreading, and mismatch repair. , 1996, Biochemistry.

[4]  N. Geacintov,et al.  The major, N2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G-->A and G-->C, in addition to G-->T, mutations. , 1995, Biochemistry.

[5]  R. Lloyd,et al.  In vivo and in Vitro Replication Consequences of Stereoisomeric Benzo[a]pyrene-7,8-dihydrodiol 9,10-Epoxide Adducts on Adenine N6 at the Second Position of N-ras Codon 61 (*) , 1995, The Journal of Biological Chemistry.

[6]  D. Jerina,et al.  Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells. , 1993, Cancer research.

[7]  M. Tomasz,et al.  Effect of site-specifically located mitomycin C-DNA monoadducts on in vitro DNA synthesis by DNA polymerases. , 1993, Biochemistry.

[8]  E. Loechler,et al.  Mutational specificity of the (+)-anti-diol epoxide of benzo[a]pyrene in a supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutagenic specificity and the extent of SOS enhancement of mutagenesis. , 1993, Carcinogenesis.

[9]  E. Loechler,et al.  Mutagenesis by the (+)-anti-diol epoxide of benzo[a]pyrene: what controls mutagenic specificity? , 1993, Biochemistry.

[10]  K. Peltonen,et al.  DNA polymerase action on benzo[a]pyrene-DNA adducts. , 1992, Carcinogenesis.

[11]  M. Benasutti,et al.  Mutagenesis by (+)-anti-B[a]P-N2-Gua, the major adduct of activated benzo[a]pyrene, when studied in an Escherichia coli plasmid using site-directed methods. , 1992, Carcinogenesis.

[12]  D. Patel,et al.  Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Jerina,et al.  Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo[a]pyrene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Essigmann,et al.  Site-specific mutagenesis: retrospective and prospective. , 1991, Carcinogenesis.

[15]  J. Mccormick,et al.  Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. E. Leclerc,et al.  Mutation frequency and spectrum resulting from a single abasic site in a single-stranded vector. , 1990, Nucleic acids research.

[17]  J. M. Roman,et al.  DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide. , 1989, Chemical research in toxicology.

[18]  J. E. Leclerc,et al.  Frequency and spectrum of mutations produced by a single cis-syn thymine-thymine cyclobutane dimer in a single-stranded vector. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Clark,et al.  Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. , 1988, Nucleic acids research.

[20]  M. Boosalis,et al.  DNA polymerase insertion fidelity. Gel assay for site-specific kinetics. , 1987, The Journal of biological chemistry.

[21]  N. Bouck,et al.  Benzo[a]pyrene diol-epoxides: different mutagenic efficiency in human and bacterial cells. , 1985, Mutation research.

[22]  W. E. Fahl,et al.  Mutation at separate gene loci in Salmonella typhimurium TA100 related to DNA nucleotide modification by stereoisomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. , 1985, Cancer research.

[23]  S. Rabkin,et al.  The role of DNA polymerase in base substitution mutagenesis on non-instructional templates. , 1982, Biochimie.

[24]  J. Miller,et al.  Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Jerina,et al.  Marked differences in the carcinogenic activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene in newborn mice. , 1978, Cancer research.

[26]  D. Jerina,et al.  Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. , 1977, Biochemical and biophysical research communications.

[27]  K. Nakanishi,et al.  BENZO(A)PYRENE-NUCLEIC ACID DERIVATIVE FOUND IN VIVO- STRUCTURE OF A BENZO(A)PYRENETETRAHYDRODIOL EPOXIDE-GUANOSINE ADDUCT , 1976 .

[28]  A. Y. Lu,et al.  Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Harris,et al.  Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. , 1976, Science.

[30]  P. Roller,et al.  Enzymatic conversion of benzo(a)pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene through a single enantiomer of r-7, t-8-dihydroxy-7,8-dihydrobenzo(a)pyrene. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Hewer,et al.  Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide , 1974, Nature.

[32]  D. Jerina,et al.  Covalent nucleoside adducts of benzo[a]pyrene 7,8-diol 9,10-epoxides: structural reinvestigation and characterization of a novel adenosine adduct on the ribose moiety , 1991 .

[33]  J. Essigmann,et al.  Site-specifically modified oligodeoxynucleotides as probes for the structural and biological effects of DNA-damaging agents. , 1988, Chemical research in toxicology.

[34]  B. Strauss Translesion DNA synthesis: polymerase response to altered nucleotides. , 1985, Cancer surveys.

[35]  M. Osborne,et al.  Mutation in mammalian cells by stereoisomers of anti-benzo[a] pyrene-diolepoxide in relation to the extent and nature of the DNA reaction products. , 1982, Carcinogenesis.

[36]  S. Rabkin,et al.  Sites of termination of in vitro DNA synthesis on ultraviolet- and N-acetylaminofluorene-treated phi X174 templates by prokaryotic and eukaryotic DNA polymerases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Slaga,et al.  Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. , 1979, Cancer research.

[38]  R. Harvey,et al.  The reaction of trans-7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene with DNA involves attack at the N7-position of guanine moieties. , 1978, Chemico-biological interactions.

[39]  A. Y. Lu,et al.  Metabolism of benzo[a]pyrene. Effect of substrate concentration and 3-methylcholanthrene pretreatment on hepatic metabolism by microsomes from rats and mice. , 1975, Archives of biochemistry and biophysics.